Assessing biomarkers of remission in female patients with anorexia nervosa (REMANO): a protocol for a prospective cohort study with a nested case-control study using clinical, neurocognitive, biological, genetic, epigenetic and neuroimaging markers in a French specialised inpatient unit.

MLA

Duriez, Philibert, et al. “Assessing Biomarkers of Remission in Female Patients with Anorexia Nervosa (REMANO): A Protocol for a Prospective Cohort Study with a Nested Case-Control Study Using Clinical, Neurocognitive, Biological, Genetic, Epigenetic and Neuroimaging Markers in a French Specialised Inpatient Unit.” BMJ Open, vol. 14, no. 6, June 2024, p. e077260. EBSCOhost, https://doi.org/10.1136/bmjopen-2023-077260.

APA

Duriez, P., Tolle, V., Ramoz, N., Kimmel, E., Charron, S., Viltart, O., Lebrun, N., Bienvenu, T., Fadigas, M., Oppenheim, C., & Gorwood, P. (2024). Assessing biomarkers of remission in female patients with anorexia nervosa (REMANO): a protocol for a prospective cohort study with a nested case-control study using clinical, neurocognitive, biological, genetic, epigenetic and neuroimaging markers in a French specialised inpatient unit. BMJ Open, 14(6), e077260. https://doi.org/10.1136/bmjopen-2023-077260

Chicago

Duriez, Philibert, Virginie Tolle, Nicolas Ramoz, Etienne Kimmel, Sylvain Charron, Odile Viltart, Nicolas Lebrun, et al. 2024. “Assessing Biomarkers of Remission in Female Patients with Anorexia Nervosa (REMANO): A Protocol for a Prospective Cohort Study with a Nested Case-Control Study Using Clinical, Neurocognitive, Biological, Genetic, Epigenetic and Neuroimaging Markers in a French Specialised Inpatient Unit.” BMJ Open 14 (6): e077260. doi:10.1136/bmjopen-2023-077260.